HOME >> BIOLOGY >> NEWS
Nerve cells 'guided' to repair spinal damage: Technique

University of Toronto researchers have designed a method to facilitate nerve cell repair that could ultimately lead to treating severed spinal cords.

The technique, outlined in the July 6 online version of Biomaterials, involves imbedding a series of fibrous rods into a gel substance and then dissolving the rods, leaving a series of longitudinal channels. These channels are then injected with peptides, molecules that stimulate cell adhesion and migration. "When nerve cells are placed at the opening of the channel, the peptides act like breadcrumbs to follow," says Molly Shoichet, lead author and professor of chemical engineering and applied chemistry at U of T's Institute for Biomaterials and Biomedical Engineering (IBBME).

According to Shoichet, the technique is part of an overall strategy to repair spinal cord injuries where the spine is cut in two. After joining the ends of the severed spine with a tube, researchers would then fill this tube with the gel channels and peptides to stimulate nerve cell growth and bridge the gap between the two ends. "We need cells to grow in a specific direction to minimize that distance, thereby reducing the time for regeneration," says Shoichet, who holds the Canada Research Chair in Tissue Engineering. "A longitudinal channel - a straight line - is the minimum distance between two points."

The research, which has yet to be tested in animal models or humans, was funded by the Natural Sciences and Engineering Research Council of Canada and an Ontario Graduate Scholarship in Science and Technology.


'"/>

Contact: Karen Kelly
k.kelly@utoronto.ca
416-978-0260
University of Toronto
16-Aug-2004


Page: 1

Related biology news :

1. Nerves, heal thyselves
2. Nerve disorder in mice and men linked to mutated gene
3. Never too late to boogie: Nerve cells still active in mature brain
4. Nerve cells death different from other cells
5. Nerve protein shown crucial to sensations of pain from heat, injury
6. Nerve cells with stoppage: Evidence for a molecular key step in the process of signal transduction between nerve cells
7. Scientists Discover Protein In Mammals Tuned To Respond To What May Be Hottest Temperature Our Nerves Can Detect
8. Nerve Cells On The Go
9. Human/Insect/Jellyfish Genes Team To Quiet "Hyper" Nerve Cells
10. Small G-Proteins Make A Big Difference -- Nerve Cell Signalling Is Regulated By Arf-GTPases And Their Activators
11. How Nerve Cells Get In Touch - A Molecular Model Of Synapse Formation And Retrograde Signalling In The Brain

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nerve cells guided repair spinal damage Technique

(Date:5/20/2013)... - A novel vaccine study from South Dakota ... will be unveiled at the American Association of Pharmaceutical ... place Monday, May 20 - Wednesday, May 22 at ... "The main goal of a vaccine is to stimulate ... causes the disease", explained Dr. Hemachand Tummala, assistant professor ...
(Date:5/19/2013)... A novel study reports that white men and women ... bunions (hallux valgus) and lesser toe deformities, including hammer ... first to estimate the heritability of foot disorders in ... journal published by Wiley on behalf of the American ... that as many as 60% of older adults have ...
(Date:5/18/2013)... MD (May 19, 2013) The AGA Research Foundation ... and Damian Augustyn Award in Digestive Cancer, which will ... of Medicine at the University of Pennsylvania, Philadelphia, as ... in pancreas development, regeneration and cancer progression. , "The ... in honor of two distinguished clinicians and AGA Legacy ...
Breaking Biology News(10 mins):Germ-fighting vaccine system makes great strides in delivery 2Blame your parents for bunion woes 2AGA Research Foundation grant furthers digestive cancer research 2
(Date:5/20/2013)... Today, at the American Psychiatric Association (APA) ... James McGough , M.D., M.S., principal investigator ... for Neuroscience and Human Behavior and David ... of California Los Angeles (UCLA), and director of clinical ... ADHD at UCLA, presented the results of a Phase ...
(Date:5/20/2013)... Biomarkers and Clinigene International are set to unveil their ... 2013 AAPS/ National Biotechnology Conference May 20-22 ... Marina , San Diego, CA. ... company representatives at their collaborative seminar, "Biosimilarity, Immunogenicity and ... 1-2 p.m. in the conference,s Spinnaker Room. ...
(Date:5/20/2013)... , May 20, 2013 Cempra, Inc. ... developing differentiated antibiotics to meet critical medical needs ... that it presented data at the American Thoracic ... Philadelphia demonstrating the antibacterial and enhanced ... prior Phase 2 clinical trial in outpatients with ...
(Date:5/20/2013)... 2013 Interventional cardiologist Tony Farah, MD, ... (AGH) Cardiovascular Institute have helped pioneer many breakthroughs ... (CAD) over the past three decades, from new ... and coronary artery stent implantation. , Today, AGH officials ... prominent role in the study of a novel, first-of-its ...
Breaking Biology Technology:Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4
Cached News: